SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that ...

H.C. Wainwright analyst Robert Burns reiterated a Buy rating on Oric Pharmaceuticals (ORIC – Research Report) today and set a price target of $21.00. Robert Burns has given his Buy rating due to ...

SOUTH SAN FRANCISCO - ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical-stage company focusing on cancer treatment resistance, has presented preclinical data on its drug candidate ORIC-114 at ...

Fintel reports that on October 31, 2024, Jones Trading initiated coverage of ORIC Pharmaceuticals (NasdaqGS:ORIC) with a Buy recommendation. As of October 22, 2024, the average one-year price ...

ORIC Pharmaceuticals (ORIC) announced the company presented a poster highlighting certain best-in-class properties of ORIC-114, a brain penetrant, orally bioavailable, irreversible EGFR/HER2 ...

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address ...

Fintel reports that on October 31, 2024, Wells Fargo initiated coverage of ORIC Pharmaceuticals (NasdaqGS:ORIC) with a Overweight recommendation. As of October 22, 2024, the average one-year price ...

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 01, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address ...

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Nov. 04, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that ...

A fake location on Google Maps named ‘Ratko Mladic Park’, placed in the middle of the Srebrenica Memorial Centre cemetery, where genocide victims are buried, has been removed after complaints ...